Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Phenethyl Alcohol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108570460B discloses novel SDR mutants enabling high-selectivity biocatalytic reduction of acetophenone derivatives, offering a greener alternative for pharmaceutical intermediate manufacturing.
Patent CN110129382B details a green enzymatic route for high-purity chiral alcohols, offering significant supply chain stability and cost efficiency for pharmaceutical intermediates.